Lake Charles Clinical Trials (LCCT) is the only research clinic specializing in psychiatric clinical trials in Southwest Louisiana (servicing a catchment area of over 200,000). Privileges at a full-service hospital-- located within the same building complex-- include access to a 46-bed inpatient psychiatric unit accommodating child, adult and geriatric patients.

Phase II - IV clinical trials for adults and adolescents in the following diagnoses:

• Bipolar disorder
• Schizophrenia
• Major depression
• Anxiety disorders
• ADHD

LCCT has worked with the following pharmaceutical companies (trials sponsors): AstraZeneca, Bristol-Myers Squibb, Janssen, Ortho-McNeil, Eli Lilly, Shire-Richwood, GlaxoSmithKline, Memory, Pfizer, Organon, Solvay, Vanda, and Wyeth. LCCT has on numerous occasions also worked with Clinical Research Organizations (CROs), including: INC Research, Ingenix, Lineberry/Constella Group, Ockham, Paragon, Parexel, PharmaNet, and Quintiles.

LCCT has conducted over twenty-five industry-sponsored trials – eight of which took place in the past year; there are ten ongoing trials at various stages of enrollment (with six more to begin in 2007).

LCCT has secure drug and data storage facilities, clinical laboratory, pharmacy, and computer-related equipment (we can capture and transmit data electronically via a T1 Internet connection), centrifuge, freezer (-20° C), refrigerator (2-8° C), EKG machine, and dry ice access.

Kashianth G. Yadalam, DFAPA - Principal Investigator (PI) Twenty-three years of combined experience and certified as a Physician Investigator by the Academy of Pharmaceutical Physicians and Investigators. Dr. Yadalam has conducted NIH-funded research and has published over 30 articles and abstracts.

Charles A. Murphy, III, MD - Sub-Investigator. Child psychiatrist for over 15 years with three years of clinical trial experience.

Charles B. Woodard, MD, FACC - Sub-InvestigatorCardiologist with almost 30 years of experience who provides medical management for all of the study participants.

Currently at LCCT, there are five full-time research coordinators as well as a records maintenance and data-monitoring support staff of seven individuals (including a phlebotomist/EKG technician, a regulatory affairs specialist, and a part-time recruiter). The coordinators have been certified by Rater Qualifying specialists in the use of diagnostic instruments and rating scales relating to the above diagnoses.

LCCT provides inpatient and outpatient treatment for child, adolescent, adult and geriatric patients

LCCT uses central Institutional Review Boards (IRBs) to monitor the ethical conduct of clinical trials and has relied/continues to rely on the oversight of the following IRBs: Aspire, Chesapeake, Coast, Copernicus, Goodwyn, Sterling, Schulman, and WIRB.

CenterWatch is listing the following trials that are actively recruiting patients at this center.

• A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients
• Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients
• Study Comparing Bifeprunox to Risperidone in the Treatment of Outpatients with Schizophrenia with Weight as the Primary Endpoint
• Switch Study of Existing Atypical Antipsychotics to Bifeprunox

For more information, please contact:

Kashinath G. Yadalam, MD, DFAPA - Certified Physician Investigator
Medical Director/ CEO
Lake Charles Clinical Trials
2770 3rd Avenue, Suite 340
Lake Charles, LA 70601 USA
Phone: 337-494-3266
Fax: 337-494-2089
E-mail:

If you are interested in contacting this center to discuss placing a clinical trial there, please complete and send the E-mail form below. A representative from the research center will then follow up with you.

Name:
Address:
City:
State:
Zip:
Phone:
Email address:
Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

Last updated on August 21, 2008